Status:
COMPLETED
Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye
Lead Sponsor:
TearScience, Inc.
Conditions:
Chalazion
Dry Eye Syndromes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the clinical utility, safety and effectiveness of the Manual Mini System compared to standardized warm compress therapy for application of controlled, locali...
Eligibility Criteria
Inclusion
- At least 18 years of age.
- Meibomian gland obstruction
- Dry eye symptoms
- Willingness to comply with study procedures and return for all visits
Exclusion
- Ocular surgery, injury, or herpes infection within past 3 months
- Active ocular infection
- Active ocular inflammation or recurrent inflammation within past 3 months
- Moderate to severe allergic conjunctivitis
- Severe eyelid inflammation
- Eyelid abnormalities that affect lid function
- Ocular surface abnormalities that may compromise corneal integrity
- Macular disease
- Systemic disease condition or medication that causes dry eye
- Use of other treatments for meibomian gland dysfunction or dry eye
- Pregnant or nursing women
- Participation in another ophthalmic clinical trial within past 30 days
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT00832130
Start Date
February 1 2009
End Date
August 1 2009
Last Update
December 12 2011
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Fayetteville, Arkansas, United States
2
Morrow, Georgia, United States
3
Highland Park, Illinois, United States
4
Edgewood, Kentucky, United States